Alvotech SEC filings ALVO

Alvotech has 302 filings in SEC EDGAR's recent list, going back to Dec 20, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 30, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 12, 2026 —
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
SC 13D/A Amended ownership over 5% (active) Jul 3, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 18, 2022 —
SC 13D/A Amended ownership over 5% (active) Jul 18, 2022 —
SC 13D/A Amended ownership over 5% (active) Jul 15, 2022 —
SC 13D Ownership over 5% (active) Jul 5, 2022 —
SC 13D Ownership over 5% (active) Jun 27, 2022 —
SC 13G Ownership over 5% (passive) Jun 22, 2022 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ALVO (Nasdaq), ALVOW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Luxembourg
Headquarters
Luxembourg, Luxembourg
SEC filer status
Large accelerated filer
SEC CIK
1898416
Former names
Alvotech Lux Holdings S.A.S. (until May 2, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.